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Case report  
 
 








In this article, we present a pregnant case suspected of COVID-19 with 
underlying symptoms of respiratory distress; which was referred to Shohada-e-
Tajrish Hospital. Due to the progressive decrease of O2 saturation, the medical 
team decided to terminate the pregnancy to save the patient's life. Despite all 
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Introduction 
Despite the dramatic and rapid increase in coronavirus 
infections (COVID 19) and cases leading to deaths, 
there are limited data about the clinical features of 
pregnant women with the disease (1). Early studies 
have claimed that the most common COVID-19 
symptoms and signs in pregnant women include: fever 
at admission (68%), dry cough (34%), malaise (13%), 
and dyspnea (12%) (2, 3). 
Nowadays, during the COVID-19 pandemic, 
maternal assessment and fetal safety are considered as 
a challenging dilemma; especially with the paucity of 
knowledge regarding pathology and management of 
COVID-19 affected pregnant women; with the 
uncertainty regarding the potential risk of vertical 
transmission (3).  
Here we discuss a pregnant mother with a 
challenging management pathway; mandating more 
sophisticated knowledge to manage these patients. 
Case Report 
A 48-years-old pregnant woman (garavid2, para1) who 
became pregnant by the administration of 
microinjection reproduction techniques, with 
Gestational Age of 28 weeks and 4 days, complaining 
of fever, shivering, dry cough, and dyspnea, was 
admitted in the COVID-19 ward in Shohada-e-Tajrish 
Hospital. 
During the primary visit and physical 
examination, the following findings were recorded: 
Blood Pressure: 110/70 mmHg, Heart Rate: 
120/minute, Respiratory Rate: 26/minute, Oral 
Temperature:38 °C, oxygen saturation by peripheral 
pulse oximetry (SpO2) in room air: 92%. At the same 
time, arterial blood gas analysis results were as 
follows: pH:7.35, PaCO2:48.5 torrs, PaO2:68.3 torrs, 
HCO3:26.2 mEq/L, O2 Saturation: 94.2%). After a 
detailed assessment, CT-angiography imaging studies 
ruled out pulmonary emboli; while Chest CT lung 
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fields showed the patchy areas of consolidation in both 
lungs accompanied by ground glass infiltrations; 
mainly suggestive of COVID-19 pneumonia (Figure 
1). 
Echocardiographic results showed that: both 
Left and Right ventricles had a normal size and good 
function, without significant valvular abnormality. 
Pulmonary artery pressure was in the normal range; 
with any sign of pulmonary emboli. With a positive 
Real-Time RT-PCR Diagnostic Panel for COVID-19, 
the intensivist started treatment with oral Oseltamivir, 
Ceftriaxone, Azithromycin, and supplemental O2 
therapy with a face mask. Two days later patient vital 
signs were as follows: Blood Pressure: 100/65mmHg, 
Pulse Rate: 125 beats per minute, Respiratory rate:30 
per minute, Oral temperature: 38.3°C and SpO2 with 
oxygen face mask:90%. Blood gas analysis revealed 
pH:7.39; partial pressure of arterial CO2 (PaCO2):51.1 
torrs, pressure of arterial oxygen (PaO2):59.3 torrs, 
arterial HCO3:30.7 mEq/L). Immediate OBGYN 
consult led to commencement of intravenous 
betamethasone. 
Forty-eight hours later, the patient’s condition 
worsened and SpO2 fell to 84% with a dramatic 
impairment in arterial blood gas parameters. So, the 
patient was immediately transferred to the operating 
room for emergency termination of pregnancy using a 
Cesarean delivery.  
As she entered the operating room, adequate 
peripheral intravenous lines were installed and the 
patient was monitored SpO2, electrocardiography, and 
noninvasive blood pressure. (Blood Pressure: 110/75 
mmHg, Pulse Rate:104/minute, Respiratory Rate: 
42/minute, Oral Temperature:37.7°C, SpO2:75%). 
The patient received spinal anesthesia and the first 
baby was born with an Apgar of 8 of 10 while the 
second baby had an Apgar 7 of 10; blood gas analysis 
assessments revealed that they were both acidotic with 
respiratory distress; so, both babies were intubated, 
transferred to NICU and died two days later. After 
surgery, the patient was transferred to ICU and 
received noninvasive using Bilevel Positive Airway 
Pressure (BIPAP). 
Two days later, the patient’s condition 
deteriorated and SpO2 fell to 52%; with severe 
impairment in blood gas parameters; while SpO2 was 
60.4%; at this time, the patient was intubated and 
invasive mechanical ventilation was started. 
On the 5th day of hospitalization, 20 mg/day 
intravenous immunoglobulin (IVIG) was started; 
added with a trial of plasmapheresis; however, none 
was effective and after a deteriorating trend, a series of 
cardiopulmonary resuscitations, the patient died on the 
15th day of hospitalization. 
 
 
Figure 1. Chest- CT showed the areas of patchy consolidation in both lungs and grand glass infiltration, which were 
primarily suggestive of COVID-19 pneumonia. 
Azizi Farsani et al.                                       Termination of Pregnancy in a Twin Pregnant Patient with COVID-19: Case Report 
 Journal of Cellular & Molecular Anesthesia (JCMA) 
208 
Discussion 
The following clinical presentations are often 
considered as deterioration in clinical COVID-19 (4-
6): 
 Respiratory rate more than >30 per minute 
 Peripheral oxygen saturation ≤93% in room air 
 Partial arterial oxygen pressure to inspired oxygen 
fraction (PaO2/FiO2) less than 300 
 Lung infiltrates more than 50% especially in 
imaging studies with CT scanning 
Close cooperation between anesthesiologists, 
gynecologists, neonatologists, intensivists, infectious 
disease specialists, and other health care teams 
followed by standard evidence-based protocols are 
integral parts for the improved outcome of pregnant 
COVID-19 affected women (4). Other Clinical 
approaches like steroids for fetal lung maturity or 
magnesium for neuroprotection, and indomethacin for 
tocolysis should be discussed; both for maternal and 
fetal safety and the sake of interactions with COVID-
19 drugs (3,4). 
To reduce the risk of anesthesia and health care 
worker in contact with COVID-19, it should be Prevent 
of urgent cesarean section. But, controlled assessment 
of both maternal and fetal status is very important (5). 
Prolonged maternal hypoxemia may eventually cause 
fetal acidosis and should be a necessary urgent 
cesarean section (6). 
Vital signs monitoring is the cornerstone of 
treatment. Supplemental oxygen is the most basic 
therapeutic modality especially if the patient 
experiences hypoxia, starting from SpO2 levels below 
93%. Non-invasive ventilation may be considered as 
an additional procedure though this modality should be 
managed with special caution regarding the potential 
risk of environmental viral shedding; however, 
invasive airway management, including endotracheal 
intubation and mechanical ventilation are the final step 
in ventilator assist approaches (7, 8).  
Based on the scantly available evidence, 
COVID-19 affected women are recommended to 
receive spinal anesthesia for a cesarean section; the 
rationale is that spinal anesthesia potentially avoids 
respiratory symptoms exacerbations and decreases the 
risk of aerosol contamination in health care workers (9, 
10). Finally, the role of delayed COVID-19 diagnosis 
and potential lack of sufficient clinical knowledge 
regarding COVID-19 in reaching a poor outcome 
should not be neglected.  
Conclusion 
To save pregnant mothers’ lives, timely diagnosis of 
the disease, and having more evidence-based 
management protocols, added with efficient teamwork 
are mandatory. 
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